Results 301 to 310 of about 169,839 (342)

Construction of Paclitaxel-Loaded Poly (2-Hydroxyethyl Methacrylate)-g-Poly (Lactide)-1,2-Dipalmitoyl-Sn-Glycero-3-Phosphoethanolamine Copolymer Nanoparticle Delivery System and Evaluation of Its Anticancer Activity [Retraction]. [PDF]

Int J Nanomedicine
europepmc   +1 more source

Cancer nanomedicine

Nature Reviews Cancer, 2022
The field of cancer nanomedicine seeks to overcome the inherent shortcomings of conventional cancer diagnostics and therapies. Yet despite the surge of interest in and attractive attributes of nanotechnologies, challenges remain in their clinical translation, prompting some to argue that they have not yet reached their true potential. In this Viewpoint
Sangeeta N Bhatia, Xiaoyuan Chen, Marina A Dobrovolskaia   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Theranostic Nanomedicine

Accounts of Chemical Research, 2011
Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents. Many different types of nanomedicines have been evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amount of evidence has been obtained ...
Lammers T., AIME, Silvio, Hennink WE, Storm G., Kiessling F.   +4 more
openaire   +6 more sources

Ultrasound Nanomedicine

Current Medicinal Chemistry, 2022

openaire   +2 more sources

Chemoreactive nanomedicine

Journal of Materials Chemistry B, 2020
Triggering specific chemical reactions in the disease microenvironment can produce species for disease treatment that have high theranostic performance and low side effects on healthy cells/tissues.
Wei Feng, Yu Chen
openaire   +2 more sources